Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cryosite

Cryosite
1999 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
CTE STOCK SYMBOL
1 INVESTMENTS
$0.04 SHARE PRICE (As of Friday Closing)
Description

Cryosite Ltd is incorporated and domiciled in Australia. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
ASX
Primary Office
  • 13a Ferndell Street South
  • Granville, New South Wales 2142
  • Australia
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cryosite’s full profile, request a free trial.

Cryosite Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.02 - $0.04 $1.73M $0.03 87.3K 46.9M

Cryosite Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value (1,353) (1,353) (304) 1,851
Revenue 5,657 5,657 4,542 7,230
EBITDA (56) (56) 349 643
Net Income (404) (404) (961) 170
Total Assets 16,228 16,228 5,688 7,552
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cryosite Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Dec-2016 000000000000000000 Other Healthcare Services
To view this company’s complete investment and acquisition history, request access »